Dana dhuwit perusahaan: Foghorn (FHTX)

Simbol resmi perusahaan Foghorn Therapeutics Inc. (FHTX)

Foghorn Therapeutics (FHTX) is innovating chromatin management via the Gene Traffic Control system for gene reprogramming. The cash balance history demonstrates liquidity dynamics, where 0.16 shapes the current metric. High risks are driven by the early stages of oncology drug development. Market capitalization relies on partnerships with pharma behemoths to create new tumor therapy methods.

Dhuwit awis lan setara dhuwit awis perusahaan: Foghorn Therapeutics Inc. (FHTX) kanggo 04.07.2022 - 21.11.2026

Rincian metrik komprehensif lan analitis Foghorn Therapeutics (FHTX)

- nilai saham lan prakiraan konsensus rega:
Pambiji fundamental:Foghorn Therapeutics Inc.
Sampel barang Foghorn

This indicator aggregates all liquid funds in accounts, determining the issuer's ability to finance operating activities without incurring debt capital. The metric's value reacts immediately to quarterly reports and investment rounds. By analyzing cash asset dynamics, an investor assesses the company's margin of safety. For Foghorn Therapeutics (FHTX), this is critical, as cash volumes determine the pace of developing costly molecules until the moment of their commercialization.